Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model
Cristoforo Incorvaia(Istituto Ortopedico Gaetano Pini), Giorgio W. Canonica(Humanitas University), N I Ilina(Federal Medical-Biological Agency), Petra Zieglmayer(Karl Landsteiner University of Health Sciences), Yoshitaka Okamoto(Chiba University), Maximiliano Gómez(Australian Catholic University), Ralph Mösges(University of Cologne), Mário Morais‐Almeida(CUF Porto Hospital), Carla Irani(Saint Joseph University), J. Christian Virchow(Universitätsmedizin Rostock), Adnan Čustović(Imperial College London), Ruby Pawankar(Nippon Medical School), Pascal Demoly(Inserm), Ignacio J. Ansotegui(Hospital Quirónsalud Barcelona), Philippe Devillier(Inserm), Andrzej Bożek(Medical University of Silesia), Robyn E. O’Hehir(The Alfred Hospital), Oliver Pfaar(Heidelberg University), Miguel Tortajada‐Girbés(Universitat de València), Ludger Klimek(Zentrum für Rhinologie und Allergologie), Paolo Maria Matricardi(Humboldt-Universität zu Berlin), Petr Panzner(Charles University), A. Didier(Hôpital Larrey), Margitta Worm(Charité - Universitätsmedizin Berlin), Claus Bachert(University Hospital Münster), Marek Jutel(Wroclaw Medical University), Alessandro Fiocchi, Catherine Bos(Stallergenes Greer (France)), Davide Caimmi(Inserm), Carmen Vidal(Universidade de Santiago de Compostela), Stefania Arasi(Bambino Gesù Children's Hospital), Thomas B. Casale(University of South Florida), Mona Al‐Ahmad(Ministry of Health), Giovanni Passalacqua(Ospedale Policlinico San Martino), Natalija Novak(University Hospital Bonn), Jean Bousquet(Charité - Universitätsmedizin Berlin), Enrico Heffler(Humanitas University), Adam Fox(Evelina London Children's Healthcare), F. de Blay(Hôpital Civil, Strasbourg), Philippe Gevaert(Ghent University), Hae‐Sim Park(Princeton University), Nikolaos G. Papadopoulos(National and Kapodistrian University of Athens), Moisés A. Calderón(Imperial College London), Ulrich Wahn(Charité - Universitätsmedizin Berlin), Oxana Kurbacheva(Federal Medical-Biological Agency), Silvia Scurati(Stallergenes Greer (France)), Piotr Kuna(Medical University of Lodz), Efstrathios Karagiannis(Stallergenes Greer (France)), Peter Schmid‐Grendelmeier(University Hospital of Zurich)
Cited by 57
Related Papers
The<i>Swift</i>Gamma‐Ray Burst Mission
|The Astrophysical Journal|2004|4.2k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
|Journal of Allergy and Clinical Immunology|2010|1.8k